Oridonin has been reported to be an effective anti‐inflammatory molecule in the treatment of gouty arthritis, type 2 diabetes, and peritonitis and it functions by inhibiting NLRP3 activation (He et al., 2018). The gene discussed is NLRP3; the disease is peritonitis.